Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2026-02-01 @ 3:15 AM
Study NCT ID:
NCT00770692
Status:
COMPLETED
Last Update Posted:
2012-11-22
First Post:
2008-10-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
Sponsor:
Eisai Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
190-150
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None